Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expanding the orbit of primary prevention--moving beyond JUPITER.

× No keyword cloud information.

16 in total

1. The Jupiter trial: key findings, controversies, and implications.

Authors: Steven E Nissen
Journal: Curr Cardiol Rep Date: 2009-03 Impact factor: 2.931

2. Commentary: C-reactive protein and risk prediction--moving beyond associations to assessing predictive utility and clinical usefulness.

Authors: Ramachandran S Vasan
Journal: Int J Epidemiol Date: 2009-01-07 Impact factor: 7.196

3. From evidence to practice: consensus in cardiovascular risk assessment and diabetes.

Authors: Michael Crooke
Journal: Clin Biochem Rev Date: 2009-11

4. Is Jupiter also a god of primary prevention?

Authors: Michel Accad; Herbert L Fred
Journal: Tex Heart Inst J Date: 2010

5. Biomarkers: hopes and challenges in the path from discovery to clinical practice.

Authors: Nikolaos G Frangogiannis
Journal: Transl Res Date: 2012-02-14 Impact factor: 7.012

6. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.

Authors: Elisabetta Poluzzi; Carlo Piccinni; Paolo Carta; Aurora Puccini; Monica Lanzoni; Domenico Motola; Alberto Vaccheri; Fabrizio De Ponti; Nicola Montanaro
Journal: Eur J Clin Pharmacol Date: 2010-12-09 Impact factor: 2.953

Review 7. Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact.

Authors: Mark J Pletcher; Michael Pignone
Journal: Circulation Date: 2011-03-15 Impact factor: 29.690

8. Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners.

Authors: Donna H Odierna; Jenny White; Susan Forsyth; Lisa A Bero
Journal: Health Expect Date: 2012-12-16 Impact factor: 3.377

9. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.

Authors: Eric Y Yang; Vijay Nambi; Zhengzheng Tang; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Brad C Astor; Thomas H Mosley; Josef Coresh; Lloyd Chambless; Christie M Ballantyne
Journal: J Am Coll Cardiol Date: 2009-12-15 Impact factor: 24.094

10. Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

Authors: Mehdi H Shishehbor; Stanley L Hazen
Journal: Cleve Clin J Med Date: 2009-01 Impact factor: 2.321